| Accuray is a radiation oncology company that develops, manufactures, sells and supports treatment solutions for radiation therapy care. Co.'s technologies are: CyberKnife Systems, which automatically track, detect and correct for tumor and patient movement in real-time during the procedure, enabling delivery of high dose radiation with sub-millimeter accuracy while patients breathe normally, without manual user intervention; and TomoTherapy Systems, including the Radixact System, which represents a radiation therapy platform specifically designed for image-guided intensity-modulated radiation therapy. Co. also provides its Onrad Treatment Delivery System in China. We show 44 historical shares outstanding datapoints in our ARAY shares outstanding history coverage, used to compute ARAY market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ARAY market cap history over the course of time is important for investors
interested in comparing ARAY's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ARAY versus a peer is one thing; comparing
ARAY market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ARAY can fluctuate over the course of history.
With this page we aim to empower investors researching ARAY by allowing them to research the ARAY market cap history.